Trigger tools, both paper and automated, have been viewed as a promising technology for patient record content analysis and identification of patient safety adverse events. The requirements and potential barriers for implementation of each line of tools have been explored by means of a literature review focusing on two interconnected subject areas: the Institute of Healthcare Improvement's paper-based Global Trigger Tool, which is currently taken up by several national level patient safety programs, and automated trigger tools, because of their increased feasibility as electronic health record (EHR) adoption grows. This paper provides an overview of the existing evidence on the strengths and weaknesses of each approach, and discusses the implications of the findings from the perspectives of healthcare organizations' management and staff, and from the viewpoint of demands on EHR systems.

Download full-text PDF

Source

Publication Analysis

Top Keywords

patient safety
12
trigger tools
12
ehr data
4
data monitoring
4
monitoring promoting
4
patient
4
promoting patient
4
safety reviewing
4
reviewing evidence
4
trigger
4

Similar Publications

Efficacy and safety of chemotherapy combined with iodine-125 seed brachytherapy for intermediate and advanced oncogenic driver gene-negative non-small cell lung cancer.

Brachytherapy

January 2025

Department of Radiology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of life Sciences and Medicine, University of Science and Technology, Hefei, Anhui 230022, PR China. Electronic address:

Purpose: To compare the effectiveness and safety of CT-guided iodine-125 seed brachytherapy in conjunction with chemotherapy against chemotherapy alone for the management of intermediate and advanced non-small cell lung cancer (NSCLC) lacking oncogenic driving genes.

Methods And Materials: Retrospective analysis was conducted on clinical data from 128 patients diagnosed with intermediate and advanced non-small cell lung cancer who received iodine-125 combined with chemotherapy or chemotherapy alone due to the absence of oncogenic driver gene mutations. The patients in two groups were compared at 6-month follow-up for objective remission rate (ORR), Disease control rate (DCR), local progression-free survival (LPFS), overall survival (OS), clinical symptom improvement, and adverse events.

View Article and Find Full Text PDF

Over the last ten years, the US Centers for Disease Control and Prevention (CDC) has organized an annual influenza forecasting challenge with the motivation that accurate probabilistic forecasts could improve situational awareness and yield more effective public health actions. Starting with the 2021/22 influenza season, the forecasting targets for this challenge have been based on hospital admissions reported in the CDC's National Healthcare Safety Network (NHSN) surveillance system. Reporting of influenza hospital admissions through NHSN began within the last few years, and as such only a limited amount of historical data are available for this target signal.

View Article and Find Full Text PDF

Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.

Gac Sanit

January 2025

Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), Valencia, Spain; Spanish Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Valencia, Spain.

Objective: To evaluate the risk of acute pancreatitis and biliary disease in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA).

Method: Population-based, propensity-weighted, new user, active comparator design study including patients with diabetes and obesity initiating treatment with GLP-1 RA or the comparator group sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in the region of Valencia from 2015 to 2021.

Results: In adjusted, per protocol main analysis, no risk differences were found for acute pancreatitis (HR: 0.

View Article and Find Full Text PDF

Intensive care unit nurses' redeployment experiences during the COVID-19 pandemic: A qualitative study.

Aust Crit Care

January 2025

Centre for Quality and Patient Safety Research - Eastern Health Partnership, Box Hill, Victoria 3128, Australia; School of Nursing and Midwifery and Centre for Quality and Patient Safety in the Institute for Health Transformation, Deakin University, Geelong, Victoria 3125, Australia.

Background: The pandemic response required the large-scale redeployment of nurses to support the care of patients with COVID-19. Surveys of staff and analysis of staff feedback indicated that the frequent redeployment of intensive care unit (ICU) registered nurses (RNs) led to dissatisfaction and contributed to voluntary reductions in hours and increased intentions to resign. Whilst much is understood about the redeployment of non-ICU RNs into ICUs to support patient care during periods of high demand, less is known about ICU RNs' experiences of being redeployed to general wards.

View Article and Find Full Text PDF

Aim: To explore migrant nurses' intrinsic and extrinsic motivations for migration and regional relocation.

Design: A qualitative descriptive study.

Methods: Semi-structured interviews were conducted among 17 migrant nurses working in a hospital in regional Australia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!